CAPS - Capstone Therapeutics Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue2,000---
Cost of Revenue254---
Gross Profit1,746---
Operating Expenses
Research Development1,3731,0391,0411,182
Selling General and Administrative5546415431,757
Non Recurring----
Total Operating Expenses2,1811,6801,5842,939
Operating Income or Loss-181-1,680-1,584-2,939
Income from Continuing Operations
Total Other Income/Expenses Net-251-111-81-24
Earnings Before Interest and Taxes-181-1,680-1,584-2,939
Interest Expense-158-70-81-81
Income Before Tax-432-1,791-1,665-2,963
Income Tax Expense-52-36-56-192
Minority Interest----
Net Income From Continuing Ops-380-1,755-1,609-2,771
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-380-1,755-663-2,771
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-380-1,755-663-2,771